Silence Therapeutics’ Partner, Quark Pharmaceuticals, Extends Its Agreement with Pfizer to Develop One of Its Compounds Containing Silence’s AtuRNAi in a New Indication Silence Therapeutics Plc noted that its partner, Quark Pharmaceuticals, has announced it has amended its existing exclusive Licensing Agreement with Pfizer. [Silence Therapeutics Plc] Press Release New Fund Established to Stimulate Regenerative Medicine Industry Pfizer Canada and the Centre for Commercialization of Regenerative Medicine (CCRM) have established the Pfizer-CCRM Innovation Fund to accelerate regenerative medicine technologies for drug screening and therapeutic applications. [Marketwire, Incorporated] Press Release Reinnervate, Roslin Cellab Ally to Develop Protocols for 3-D Growth of hESCs Reinnervate and Roslin Cellab are joining forces to develop protocols for the 3-D growth of human embryonic stem cells (hESCs). Roslin Cellab’s expertise in developing and delivering custom tools and protocols in the field of hESC biology will be coupled with Reinnervate’s Alvetex®Scaffold technology. [Genetic Engineering & Biotechnology News] Press Release DSM Agrees to Acquire Kensey Nash to Strengthen Its Biomedical Business The purchase by DSM of Kensey Nash will strengthen and complement DSM Biomedical’s business and capabilities, while clearly meeting DSM’s financial and strategic criteria. [Royal DSM] Press Release The Ludwig Institute for Cancer Research Announces Launch of iTeos Therapeutics SA The Ludwig Institute for Cancer Research announced the launch of a private biotechnology enterprise, iTeos Therapeutics SA, to develop a novel pre-clinical pipeline of immunomodulators to stimulate the immune system’s ability to attack cancer. [Ludwig Institute for Cancer Research Ltd] Press Release Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary – Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding Bio-Matrix Scientific Group, Inc. announced it has formed a new subsidiary, Regen BioPharma, Inc. Regen BioPharma has developed a vertically-integrated structure for acquiring patents, performing accelerating preclinical and clinical development, and licensing or selling technology developed to large pharma companies in the area of stem cells. [Marketwire, Incorporated] Press Release UM’s Interdisciplinary Stem Cell Institute Awarded $10 Million Grant from Starr Foundation The grant will support the University of Miami (UM) Miller School of Medicine’s Interdisciplinary Stem Cell Institute in broadening its preclinical and clinical research on stem cells, and help accelerate its pipeline of translational research and programs for a wide range of debilitating conditions including cardiac disease, cancer, wound healing, stroke, glaucoma and chronic kidney and gastrointestinal diseases. [University of Miami Miller School of Medicine] Press Release Northwest Bio Awarded $5.5 Million German Government Grant The grant will reimburse fifty percent of the costs for manufacturing in Germany and for Northwest Biotherapeutics, Inc.’s clinical trial with DCVax®-L for brain cancer at up to 30 clinical sites in Germany. [Northwest Biotherapeutics, Inc.] Press Release Families of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophy Families of SMA announced the award of up to $750,000 for an important new grant to Dr. Brian Kaspar at Nationwide Children’s Hospital. This award will support preclinical development of a CNS-delivered Gene Therapy for Spinal Muscular Atrophy. [Families of SMA] Press Release First Fellowships Awarded in New Canadian Stem Cell and Regenerative Medicine Research Program The first two postdoctoral research fellowships of a new program to promote stem cell research in Canada were announced by the program’s sponsors, Canada’s Stem Cell Network and Pfizer. [Stem Cell Network] Press Release Substantial EU Framework Programme 7 Grant Awarded for Clinical Development of Ark’s Pre-Clinical Product Candidate EG013 in the Treatment of Fetal Growth Restriction Ark Therapeutics Group plc announced it has received notice of the award of an EU Framework Programme 7 Grant of up to €6 million to a consortium led by UCL in which Ark is the sole industrial partner engaged in the research. EG013 is an adenoviral vector containing the vascular endothelial growth factor gene under development by Ark for the treatment of severe fetal growth restriction in pregnant women during the second trimester. [Ark Therapeutics Group plc] Press Release BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device BioRestorative Therapies, Inc. announced that the latest version of its stem cell disc delivery device, which is to be used in the treatment of bulging and herniated discs, has shown improvements when compared to earlier versions. [PR Newswire] Press Release American CryoStem Announces ACS Laboratories Adipose Tissue and Adult Stem Cell Testing Services American CryoStem Corporation announced the launch of its new adipose tissue and adult stem cell testing services to assist physicians involved in tissue engraftment, regenerative medicine procedures and cellular therapies utilizing adult adipose derived stem cells. [American CryoStem Corporation] Press Release Cryo-Cell International Taps Leader in Stem Cell Therapy to Serve as Chief Scientific Officer Cryo-Cell International, Inc. announced the appointment of Linda Kelley, Ph.D., as chief scientific officer. Dr. Kelley is responsible for overseeing Cryo-Cells state-of-the art laboratory, translational medicine initiatives and quality assurance program at its stem cell and cord blood banking facility in Oldsmar, Florida. [Reuters] Press Release |